Food for thought: Dietary changes in essential fatty acid ratios and the increase in autism spectrum disorders

Neuroscience and Biobehavioral Reviews

Volumn 45, Issue , 2014, Pages 369-378

  van Elst, Kim ^a   Bruining, Hilgo ^a   Birtoli, Barbara ^b   Terreaux, Christian ^b   Buitelaar, Jan K ^c   Kas, Martien J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Vifor (International) Inc   (Switzerland)

^c RADBOUD UNIVERSITY   (Netherlands)

Author keywords

AA; Autism spectrum disorders; Brain deficiency; Development; DHA; Diet; Docosahexaenoic acid; Humans; Mice; Omega 3; Omega 6; Polyunsaturated fatty acids; PUFA

Indexed keywords

CHOLESTEROL; ESSENTIAL FATTY ACID; NEUROTRANSMITTER; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID; 4 AMINOBUTYRIC ACID; INTERLEUKIN DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN;

ADD ON THERAPY; AUTISM; BEHAVIOR DISORDER; BRAIN DEVELOPMENT; COGNITION; DEVELOPMENTAL BIOLOGY; DEVELOPMENTAL DISORDER; DIET SUPPLEMENTATION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; ESSENTIAL FATTY ACID DEFICIENCY; FAT INTAKE; FATTY ACID METABOLISM; FATTY ACID SYNTHESIS; HUMAN; INFLAMMATORY DISEASE; LIPID COMPOSITION; LIPID MEMBRANE; MEDICAL RESEARCH; NERVE CELL DIFFERENTIATION; NEUROANATOMY; NOMENCLATURE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SYNAPTOGENESIS; BRAIN DISEASE; CLINICAL RESEARCH; DIETARY INTAKE; EXPERIMENTAL STUDY; MOLECULAR MECHANICS; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; ANIMAL; BRAIN; CHILD DEVELOPMENT DISORDERS, PERVASIVE; DIET; GROWTH, DEVELOPMENT AND AGING; METABOLISM;

ANIMALS; BRAIN; CHILD DEVELOPMENT DISORDERS, PERVASIVE; DIET; FATTY ACIDS, ESSENTIAL; HUMANS;

EID: 84905224875     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2014.07.004     Document Type: Review

References (174)

1. Abbott B.D. Review of the expression of peroxisome proliferator-activated receptors alpha (PPAR alpha), beta (PPAR beta), and gamma (PPAR gamma) in rodent and human development. Reprod. Toxicol. 2009, 27:246-257.
2. Al-Farsi Y.M., Waly M.I., Deth R.C., Al-Sharbati M.M., Al-Shafaee M., Al-Farsi O., Al-Khaduri M.M., Al-Adawi S., Hodgson N.W., Gupta I., Ouhtit A. Impact of nutrition on serum levels of docosahexaenoic acid among Omani children with autism. Nutrition 2013, 29:1142-1146.
3. Alessandri J.M., Guesnet P., Vancassel S., Astorg P., Denis I., Langelier B., Aid S., Poumes-Ballihaut C., Champeil-Potokar G., Lavialle M. Polyunsaturated fatty acids in the central nervous system: evolution of concepts and nutritional implications throughout life. Reprod. Nutr. Dev. 2004, 44:509-538.
4. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R) 1987, American Psychiatric Association, Washington, DC. 3rd revised ed.
5. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) 2000, American Psychiatric Association, Washington, DC. 4th ed.
6. Amminger G.P., Berger G.E., Schafer M.R., Klier C., Friedrich M.H., Feucht M. Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Biol. Psychol. 2007, 61:551-553.
7. Anderson G.J., Neuringer M., Lin D.S., Connor W.E. Can prenatal n-3 fatty acid deficiency be completely reversed after birth? Effects on retinal and brain biochemistry and visual function in rhesus monkeys. Pediatr. Res. 2005, 58:865-872.
8. Aoyama T., Peters J.M., Iritani N., Nakajima T., Furihata K., Hashimoto T., Gonzalez F.J. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J. Biol. Chem. 1998, 273:5678-5684.
9. Baird G., Simonoff E., Pickles A., Chandler S., Loucas T., Meldrum D., Charman T. Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP). Lancet 2006, 368:210-215.
10. Bauman M., Kemper T.L. Histoanatomic observations of the brain in early infantile autism. Neurology 1985, 35:866-874.
11. Bauman M.L., Kemper T.L. Neuroanatomic observations of the brain in autism: a review and future directions. Int. J. Dev. Neurosci. 2005, 23:183-187.
12. 2 in autistic spectrum disorders. Prostaglandins Leukot. Essent. Fatty Acids 2004, 71:201-204.
13. Bell J.G., Sargent J.R., Tocher D.R., Dick J.R. Red blood cell fatty acid compositions in a patient with autistic spectrum disorder: a characteristic abnormality in neurodevelopmental disorders?. Prostaglandins Leukot. Essent. Fatty Acids 2000, 63:21-25.
14. Bent S., Bertoglio K., Ashwood P., Bostrom A., Hendren R.L. A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder. J. Autism Dev. Disord. 2011, 41:545-554.
15. Berg J.M., Tymoczko J.L., Stryer L. Biochemistry 2007, W.H. Freeman and Company, New York.
16. Bernardi J.R., Escobar R.S., Ferreira C.F., Silveira P.P. Fetal and neonatal levels of omega-3: effects on neurodevelopment, nutrition, and growth. Sci. World J. 2012, 2012:202473.
17. Blasbalg T.L., Hibbeln J.R., Ramsden C.E., Majchrzak S.F., Rawlings R.R. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am. J. Clin. Nutr. 2011, 93:950-962.
18. Blatt G.J., Fatemi S.H. Alterations in GABAergic biomarkers in the autism brain: research findings and clinical implications. Anat. Rec. (Hoboken) 2011, 294:1646-1652.
19. Bourre J.M. Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing. J. Nutr. Health Aging 2004, 8:163-174.
20. Breckenridge W.C., Gombos G., Morgan I.G. The lipid composition of adult rat brain synaptosomal plasma membranes. Biochim. Biophys. Acta 1972, 266:695-707.
21. Brenna J.T., Lapillonne A. Background paper on fat and fatty acid requirements during pregnancy and lactation. Ann. Nutr. Metab. 2009, 55:97-122.
22. Brooker R.J., Widmaier E.P., Graham L.E., Stiling P.D. Membrane structure and transport. Biology 2008, 85-104. McGraw-Hill, New York. P.E. Reudy (Ed.).
23. Burdge G.C., Lillycrop K.A. Fatty acids and epigenetics. Curr. Opin. Clin. Nutr. Metab. Care 2014, 17:156-161.
24. Burdge G.C., Wootton S.A. Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br. J. Nutr. 2002, 88:411-420.
25. Burgess N.K., Sweeten T.L., McMahon W.M., Fujinami R.S. Hyperserotoninemia and altered immunity in autism. J. Autism Dev. Disord. 2006, 36:697-704.
26. Burr G.O., Burr M.M. On the nature and role of the fatty acids essential in nutrition. J. Biol. Chem. 1930, 86:587-621.
27. Calder P.C., Grimble R.F. Polyunsaturated fatty acids, inflammation and immunity. Eur. J. Clin. Nutr. 2002, 56(Suppl. 3):S14-S19.
28. Calderon F., Kim H.Y. Docosahexaenoic acid promotes neurite growth in hippocampal neurons. J. Neurochem. 2004, 90:979-988.
29. Cao D., Kevala K., Kim J., Moon H.S., Jun S.B., Lovinger D., Kim H.Y. Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function. J. Neurochem. 2009, 111:510-521.
30. Careaga M., Van de Water J., Ashwood P. Immune dysfunction in autism: a pathway to treatment. Neurotherapeutics 2010, 7:283-292.
31. Carrie I., Clement M., de Javel D., Frances H., Bourre J.M. Phospholipid supplementation reverses behavioral and biochemical alterations induced by n-3 polyunsaturated fatty acid deficiency in mice. J. Lipid Res. 2000, 41:473-480.
32. Centers for Disease Control and Prevention Prevalence of autism spectrum disorders - autism and developmental disabilities monitoring network, 14 sites, United States, 2002. Morb. Mortal. Wkly. Rep. 2007, 56:12-28.
33. Centers for Disease Control and Prevention Prevalence of autism spectrum disorders - autism and developmental disabilities monitoring network, United States, 2006. Morb. Mortal. Wkly. Rep. 2009, 58:1-20.
34. Centers for Disease Control and Prevention Prevalence of autism spectrum disorders - autism and developmental disabilities monitoring network, 14 sites, United States, 2008. Morb. Mortal. Wkly. Rep. 2012, 61:1-19.
35. Centers for Disease Control and Prevention Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010. Morb. Mortal. Wkly. Rep. 2014, 63:1-21.
36. Chaiyasit W., Elias R.J., McClements D.J., Decker E.A. Role of physical structures in bulk oils on lipid oxidation. Crit. Rev. Food Sci. Nutr. 2007, 47:299-317.
37. Chaste P., Leboyer M. Autism risk factors: genes, environment, and gene-environment interactions. Dialogues Clin. Neurosci. 2012, 14:281-292.
38. Chen C.T., Green J.T., Orr S.K., Bazinet R.P. Regulation of brain polyunsaturated fatty acid uptake and turnover. Prostaglandins Leukot. Essent. Fatty Acids 2008, 79:85-91.
39. Christensen J.H., Schmidt E.B., Svensson M. n-3 polyunsaturated fatty acids, lipids and lipoproteins in end-stage renal disease. Clin. Lipidol. 2011, 6:563-576.
40. Chugani D.C., Muzik O., Behen M., Rothermel R., Janisse J.J., Lee J., Chugani H.T. Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann. Neurol. 1999, 45:287-295.
41. Chung W.L., Chen J.J., Su H.M. Fish oil supplementation of control and (n-3) fatty acid-deficient male rats enhances reference and working memory performance and increases brain regional docosahexaenoic acid levels. J. Nutr. 2008, 138:1165-1171.
42. Clark-Taylor T., Clark-Taylor B.E. Is autism a disorder of fatty acid metabolism? Possible dysfunction of mitochondrial beta-oxidation by long chain acyl-CoA dehydrogenase. Med. Hypotheses 2004, 62:970-975.
43. Cook E.H., Courchesne R., Lord C., Cox N.J., Yan S., Lincoln A., Haas R., Courchesne E., Leventhal B.L. Evidence of linkage between the serotonin transporter and autistic disorder. Mol. Psychiatry 1997, 2:247-250.
44. Cordain L., Eaton S.B., Sebastian A., Mann N., Lindeberg S., Watkins B.A., O'Keefe J.H., Brand-Miller J. Origins and evolution of the Western diet: health implications for the 21st century. Am. J. Clin. Nutr. 2005, 81:341-354.
45. Coti Bertrand P., O'Kusky J.R., Innis S.M. Maternal dietary (n-3) fatty acid deficiency alters neurogenesis in the embryonic rat brain. J. Nutr. 2006, 136:1570-1575.
46. Courchesne E. Abnormal early brain development in autism. Mol. Psychiatry 2002, 7(Suppl. 2):S21-S23.
47. Courchesne E., Pierce K. Brain overgrowth in autism during a critical time in development: implications for frontal pyramidal neuron and interneuron development and connectivity. Int. J. Dev. Neurosci. 2005, 23:153-170.
48. Crawford M.A. Fatty-acid ratios in free-living and domestic animals. Lancet 1968, 291:1329-1333.
49. D'Hulst C., Atack J.R., Kooy R.F. The complexity of the GABA(A) receptor shapes unique pharmacological profiles. Drug Discov. Today 2009, 14:866-875.
50. Das U.N. Long-chain polyunsaturated fatty acids and metabolic syndrome X. Nutrients, Stress, and Medical Disorders 2006, 317-324. Humana Press Inc., Totowa, NJ. S. Yehuda, D.I. Mostofsky (Eds.).
51. Das U.N. Nutritional factors in the pathobiology of autism. Nutrition 2013, 29:1066-1069.
52. de La Presa Owens S., Innis S.M. Docosahexaenoic and arachidonic acid prevent a decrease in dopaminergic and serotoninergic neurotransmitters in frontal cortex caused by a linoleic and alpha-linolenic acid deficient diet in formula-fed piglets. J. Nutr. 1999, 129:2088-2093.
53. Delion S., Chalon S., Guilloteau D., Besnard J.C., Durand G. Alpha-linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex. J. Neurochem. 1996, 66:1582-1591.
54. Delion S., Chalon S., Herault J., Guilloteau D., Besnard J.C., Durand G. Chronic dietary alpha-linolenic acid deficiency alters dopaminergic and serotoninergic neurotransmission in rats. J. Nutr. 1994, 124:2466-2476.
55. Delorme R., Ey E., Toro R., Leboyer M., Gillberg C., Bourgeron T. Progress toward treatments for synaptic defects in autism. Nat. Med. 2013, 19:685-694.
56. Depino A.M. Peripheral and central inflammation in autism spectrum disorders. Mol. Cell. Neurosci. 2013, 53:69-76.
57. Duchan E., Patel D.R. Epidemiology of autism spectrum disorders. Pediatr. Clin. North Am. 2012, 59:27-43.
58. Dyall S.C., Michael G.J., Michael-Titus A.T. Omega-3 fatty acids reverse age-related decreases in nuclear receptors and increase neurogenesis in old rats. J. Neurosci. Res. 2010, 88:2091-2102.
59. Eaton S.B., Eaton Iii S.B. Paleolithic vs. modern diets - selected pathophysiological implications. Eur. J. Nutr. 2000, 39:67-70.
60. Eaton S.B., Eaton Iii S.B., Sinclair A.J., Cordain L., Mann N.J. Dietary intake of long-chain polyunsaturated fatty acids during the paleolithic. The Return of ω3 Fatty Acids into the Food Supply 1998, 12-23. Karger, Basel. A.P. Simopoulos (Ed.).
61. Ebert D.H., Greenberg M.E. Activity-dependent neuronal signalling and autism spectrum disorder. Nature 2013, 493:327-337.
62. Eckert G.P., Lipka U., Muller W.E. Omega-3 fatty acids in neurodegenerative diseases: focus on mitochondria. Prostaglandins Leukot. Essent. Fatty Acids 2012, 88:105-114.
63. El-Ansary A.K., Bacha A.G., Al-Ayahdi L.Y. Impaired plasma phospholipids and relative amounts of essential polyunsaturated fatty acids in autistic patients from Saudi Arabia. Lipids Health Dis. 2011, 10:63.
64. El-Ansary A.K., Bacha A.G., Al-Ayahdi L.Y. Plasma fatty acids as diagnostic markers in autistic patients from Saudi Arabia. Lipids Health Dis. 2011, 10:62.
65. European Commission Some Elements About the Prevalence of Autism Spectrum Disorders (ASD) in the European Union 2005, European Commission, Luxembourg. Directorate C - Public Health and Risk Assessment (Ed.).
66. Filipek P.A., Juranek J., Nguyen M.T., Cummings C., Gargus J.J. Relative carnitine deficiency in autism. J. Autism Dev. Disord. 2004, 34:615-623.
67. Fokkema M.R., Brouwer D.A., Hasperhoven M.B., Hettema Y., Bemelmans W.J., Muskiet F.A. Polyunsaturated fatty acid status of Dutch vegans and omnivores. Prostaglandins Leukot. Essent. Fatty Acids 2000, 63:279-285.
68. Fombonne E. Epidemiology of pervasive developmental disorders. Pediatr. Res. 2009, 65:591-598.
69. Fombonne E., Quirke S., Hagen A. Prevalence and interpretation of recent trends in rates of pervasive developmental disorders. McGill J. Med. 2009, 12:73.
70. Frances H., Monier C., Bourre J.M. Effects of dietary alpha-linolenic acid deficiency on neuromuscular and cognitive functions in mice. Life Sci. 1995, 57:1935-1947.
71. Gerrior S., Bente L., Hiza H.A.B. Nutrient Content of the US Food Supply, 1909-2000. Home Economics Research Report No. 56 2004, 1-158. US Department of Agriculture, Center for Nutrition Policy and Promotion.
72. Gesundheit B., Rosenzweig J.P., Naor D., Lerer B., Zachor D.A., Prochazka V., Melamed M., Kristt D.A., Steinberg A., Shulman C., Hwang P., Koren G., Walfisch A., Passweg J.R., Snowden J.A., Tamouza R., Leboyer M., Farge-Bancel D., Ashwood P. Immunological and autoimmune considerations of autism spectrum disorders. J. Autoimmun. 2013, 44:1-7.
73. Glomset J.A. Role of docosahexaenoic acid in neuronal plasma membranes. Sci. STKE. 2006, 321:pe6.
74. 2 in releasing docosahexaenoic acid from brain phospholipids. J. Lipid Res. 2008, 49:939-944.
75. Greenberg J.A., Bell S.J., Ausdal W.V. Omega-3 fatty acid supplementation during pregnancy. Rev. Obstet. Gynecol. 2008, 1:162-169.
76. Guesnet P., Alessandri J.M. Docosahexaenoic acid (DHA) and the developing central nervous system (CNS) - implications for dietary recommendations. Biochimie 2011, 93:7-12.
77. Gurney J.G., Fritz M.S., Ness K.K., Sievers P., Newschaffer C.J., Shapiro E.G. Analysis of prevalence trends of autism spectrum disorder in Minnesota. Arch. Pediatr. Adolesc. Med. 2003, 157:622-627.
78. Hagberg H., Gressens P., Mallard C. Inflammation during fetal and neonatal life: implications for neurologic and neuropsychiatric disease in children and adults. Ann. Neurol. 2012, 71:444-457.
79. Hajjar T., Meng G.Y., Rajion M.A., Vidyadaran S., Othman F., Farjam A.S., Li T.A., Ebrahimi M. Omega 3 polyunsaturated fatty acid improves spatial learning and hippocampal peroxisome proliferator activated receptors (PPARalpha and PPARgamma) gene expression in rats. BMC Neurosci. 2012, 13:109.
80. Halliwell B., Murcia M.A., Chirico S., Aruoma O.I. Free radicals and antioxidants in food and in vivo: what they do and how they work. Crit. Rev. Food Sci. Nutr. 1995, 35:7-20.
81. Hamazaki T., Hamazaki K. Fish oils and aggression or hostility. Prog. Lipid Res. 2008, 47:221-232.
82. Hendren R.L., Bertoglio K., Ashwood P., Sharp F. Mechanistic biomarkers for autism treatment. Med. Hypotheses 2009, 73:950-954.
83. Herault J., Petit E., Martineau J., Cherpi C., Perrot A., Barthelemy C., Lelord G., Muh J.P. Serotonin and autism: biochemical and molecular biology features. Psychiatry Res. 1996, 65:33-43.
84. Herbert M.R. Large brains in autism: the challenge of pervasive abnormality. Neuroscientist 2005, 11:417-440.
85. Herbert M.R., Ziegler D.A., Deutsch C.K., O'Brien L.M., Lange N., Bakardjiev A., Hodgson J., Adrien K.T., Steele S., Makris N., Kennedy D., Harris G.J., Caviness V.S. Dissociations of cerebral cortex, subcortical and cerebral white matter volumes in autistic boys. Brain 2003, 126:1182-1192.
86. Hiza H.A.B., Bente L. Nutrient Content of the US Food Supply: Developments Between 2000 and 2006. Home Economics Research Report No. 59 2011, 1-61. US Department of Agriculture, Center for Nutrition Policy and Promotion.
87. Innis S.M. Essential fatty acids in growth and development. Prog. Lipid Res. 1991, 30:39-103.
88. Innis S.M. Dietary omega 3 fatty acids and the developing brain. Brain Res. 2008, 1237:35-43.
89. Innis S.M., de La Presa Owens S. Dietary fatty acid composition in pregnancy alters neurite membrane fatty acids and dopamine in newborn rat brain. J. Nutr. 2001, 131:118-122.
90. James S., Montgomery P., Williams K. Omega-3 fatty acids supplementation for autism spectrum disorders (ASD). Cochrane Database Syst. Rev. 2011, CD007992.
91. Jones K.L., Will M.J., Hecht P.M., Parker C.L., Beversdorf D.Q. Maternal diet rich in omega-6 polyunsaturated fatty acids during gestation and lactation produces autistic-like sociability deficits in adult offspring. Behav. Brain Res. 2013, 238:193-199.
92. Kawakita E., Hashimoto M., Shido O. Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Neuroscience 2006, 139:991-997.
93. Keys A., Anderson J.T., Grande F. Serum-cholesterol response to dietary fat. Lancet 1957, 1:787.
94. Kim H.Y., Spector A.A., Xiong Z.M. A synaptogenic amide N-docosahexaenoylethanolamide promotes hippocampal development. Prostaglandins Other Lipid Mediat. 2011, 96:114-120.
95. A receptor ligand-binding. Biochem. Pharmacol. 1992, 44:11-15.
96. Kopecky J., Rossmeisl M., Flachs P., Kuda O., Brauner P., Jilkova Z., Stankova B., Tvrzicka E., Bryhn M. n-3 PUFA: bioavailability and modulation of adipose tissue function. Proc. Nutr. Soc. 2009, 68:361-369.
97. Kris-Etherton P.M., Hill A.M. n-3 fatty acids: food or supplements?. J. Am. Diet. Assoc. 2008, 108:1125-1130.
98. Kritchevsky D. History of recommendations to the public about dietary fat. J. Nutr. 1998, 128:449S-452S.
99. Kubow S. Routes of formation and toxic consequences of lipid oxidation products in foods. Free Radic. Biol. Med. 1992, 12:63-81.
100. Kubow S. Lipid oxidation products in food and atherogenesis. Nutr. Rev. 1993, 51:33-40.
101. Larrieu T., Madore C., Joffre C., Laye S. Nutritional n-3 polyunsaturated fatty acids deficiency alters cannabinoid receptor signaling pathway in the brain and associated anxiety-like behavior in mice. J. Physiol. Biochem. 2012, 68:671-681.
102. Larsson H.J., Eaton W.W., Madsen K.M., Vestergaard M., Olesen A.V., Agerbo E., Schendel D., Thorsen P., Mortensen P.B. Risk factors for autism: perinatal factors, parental psychiatric history, and socioeconomic status. Am. J. Epidemiol. 2005, 161:916-925.
103. Laye S., Dantzer R. Polyunsaturated fatty acids and neuro-inflammation. Nutrients, Stress and Medical Disorders 2006, 353-374. Humana Press Inc., Totowa, NJ. S. Yehuda, D.I. Mostofsky (Eds.).
104. Levant B., Radel J.D., Carlson S.E. Decreased brain docosahexaenoic acid during development alters dopamine-related behaviors in adult rats that are differentially affected by dietary remediation. Behav. Brain Res. 2004, 152:49-57.
105. Liu J.F., Huang C.J. Tissue alpha-tocopherol retention in male rats is compromised by feeding diets containing oxidized frying oil. J. Nutr. 1995, 125:3071-3080.
106. Luchtman D.W., Song C. Cognitive enhancement by omega-3 fatty acids from child-hood to old age: findings from animal and clinical studies. Neuropharmacology 2013, 64:550-565.
107. Maekawa M., Iwayama Y., Arai R., Nakamura K., Ohnishi T., Toyota T., Tsujii M., Okazaki Y., Osumi N., Owada Y., Mori N., Yoshikawa T. Polymorphism screening of brain-expressed FABP7, 5 and 3 genes and association studies in autism and schizophrenia in Japanese subjects. J. Hum. Genet. 2010, 55:127-130.
108. Mahoney A.D., Minter B., Burch K., Stapel-Wax J. Autism spectrum disorders and prematurity: a review across gestational age subgroups. Adv. Neonatal Care 2013, 13:247-251.
109. Manning S.E., Davin C.A., Barfield W.D., Kotelchuck M., Clements K., Diop H., Osbahr T., Smith L.A. Early diagnoses of autism spectrum disorders in Massachusetts birth cohorts, 2001-2005. Pediatrics 2011, 127:1043-1051.
110. Martin R.E., Bazan N.G. Changing fatty acid content of growth cone lipids prior to synaptogenesis. J. Neurochem. 1992, 59:318-325.
111. Martinez M., Mougan I. Fatty acid composition of human brain phospholipids during normal development. J. Neurochem. 1998, 71:2528-2533.
112. McDougle C.J., Naylor S.T., Cohen D.J., Aghajanian G.K., Heninger G.R., Price L.H. Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch. Gen. Psychiatry 1996, 53:993-1000.
113. McNamara R.K., Able J., Liu Y., Jandacek R., Rider T., Tso P., Lipton J.W. Omega-3 fatty acid deficiency during perinatal development increases serotonin turnover in the prefrontal cortex and decreases midbrain tryptophan hydroxylase-2 expression in adult female rats: dissociation from estrogenic effects. J Psychiatr Res. 2009, 43(6):656-663.
114. Meguid N.A., Atta H.M., Gouda A.S., Khalil R.O. Role of polyunsaturated fatty acids in the management of Egyptian children with autism. Clin. Biochem. 2008, 41:1044-1048.
115. Meiri G., Bichovsky Y., Belmaker R.H. Omega 3 fatty acid treatment in autism. J Child Adolesc. Psychopharmacol. 2009, 19:449-451.
116. Michalik L., Auwerx J., Berger J.P., Chatterjee V.K., Glass C.K., Gonzalez F.J., Grimaldi P.A., Kadowaki T., Lazar M.A., O'Rahilly S., Palmer C.N., Plutzky J., Reddy J.K., Spiegelman B.M., Staels B., Wahli W. International Union of Pharmacology: LXI. Peroxisome proliferator-activated receptors. Pharmacol. Rev. 2006, 58:726-741.
117. Moriguchi T., Greiner R.S., Salem N. Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration. J. Neurochem. 2000, 75:2563-2573.
118. Moriguchi T., Loewke J., Garrison M., Catalan J.N., Salem N. Reversal of docosahexaenoic acid deficiency in the rat brain, retina, liver, and serum. J. Lipid Res. 2001, 42:419-427.
119. Nakashima Y., Yuasa S., Hukamizu Y., Okuyama H., Ohhara T., Kameyama T., Nabeshima T. Effect of a high linoleate and a high alpha-linolenate diet on general behavior and drug sensitivity in mice. J. Lipid Res. 1993, 34:239-247.
120. Nazeer A., Ghaziuddin M. Autism spectrum disorders: clinical features and diagnosis. Pediatr. Clin. North Am. 2012, 59:19-25.
121. Newschaffer C.J., Falb M.D., Gurney J.G. National autism prevalence trends from United States special education data. Pediatrics 2005, 115:E277-E282.
122. Nicholas J.S., Charles J.M., Carpenter L.A., King L.B., Jenner W., Spratt E.G. Prevalence and characteristics of children with autism-spectrum disorders. Ann. Epidemiol. 2008, 18:130-136.
123. Olsen S.F., Sorensen J.D., Secher N.J., Hedegaard M., Henriksen T.B., Hansen H.S., Grant A. Randomized controlled trial of effect of fish-oil supplementation on pregnancy duration. Lancet 1992, 339:1003-1007.
124. Onore C., Careaga M., Ashwood P. The role of immune dysfunction in the pathophysiology of autism. Brain Behav. Immun. 2012, 26:383-392.
125. Pardo C.A., Eberhart C.G. The neurobiology of autism. Brain Pathol. 2007, 17:434-447.
126. Pawlosky R.J., Hibbeln J.R., Novotny J.A., Salem N. Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. J. Lipid Res. 2001, 42:1257-1265.
127. Poduslo S.E., Jang Y. Myelin development in infant brain. Neurochem. Res. 1984, 9:1615-1626.
128. Politi P., Rocchetti M., Emanuele E., Rondanelli M., Barale F. Randomized placebo-controlled trials of omega-3 polyunsaturated fatty acids in psychiatric disorders: a review of current literature. Curr. Drug Discov. Technol. 2013, 10:245-253.
129. Raygada M., Cho E., Hilakivi-Clarke L. High maternal intake of polyunsaturated fatty acids during pregnancy in mice alters offsprings' aggressive behavior, immobility in the swim test, locomotor activity and brain protein kinase C activity. J. Nutr. 1998, 128:2505-2511.
130. Richardson A.J. Clinical trials of fatty acid treatment in ADHD, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins Leukot. Essent. Fatty Acids 2004, 70:383-390.
131. Richardson A.J. Long-chain polyunsaturated fatty acids in childhood developmental and psychiatric disorders. Lipids 2004, 39:1215-1222.
132. Richardson A.J. Omega-3 fatty acids in ADHD and related neurodevelopmental disorders. Int. Rev. Psychiatry 2006, 18:155-172.
133. Richardson A.J., Ross M.A. Fatty acid metabolism in neurodevelopmental disorder: a new perspective on associations between attention-deficit/hyperactivity disorder, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins Leukot. Essent. Fatty Acids 2000, 63:1-9.
134. Ritvo E.R., Freeman B.J., Pingree C., Masonbrothers A., Jorde L., Jenson W.R., McMahon W.M., Petersen P.B., Mo A., Ritvo A. The UCLA-university-of-Utah epidemiologic survey of autism: prevalence. Am. J. Psychiatry 1989, 146:194-199.
135. Roseth S., Fykse E.M., Fonnum F. The effect of arachidonic acid and free fatty acids on vesicular uptake of glutamate and gamma-aminobutyric acid. Eur. J. Pharmacol. 1998, 341:281-288.
136. Rutter M. Diagnosis and definition of childhood autism. J. Autism Dev. Disord. 1978, 8:139-161.
137. Salem N., Pawlosky R., Wegher B., Hibbeln J. In vivo conversion of linoleic acid to arachidonic acid in human adults. Prostaglandins Leukot. Essent. Fatty Acids 1999, 60:407-410.
138. Salvati S., Attorri L., Avellino C., Di B.A., Sanchez M. Diet, lipids and brain development. Dev. Neurosci. 2000, 22:481-487.
139. Sanders T.A.B. Essential fatty acid requirements of vegetarians in pregnancy, lactation, and infancy. Am. J. Clin. Nutr. 1999, 70:555S-559S.
140. Schain R.J., Freedman D.X. Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. J. Pediatr. 1961, 58:315-320.
141. Schiefermeier M., Yavin E. n-3 deficient and docosahexaenoic acid-enriched diets during critical periods of the developing prenatal rat brain. J. Lipid Res. 2002, 43:124-131.
142. Schmitz G., Ecker J. The opposing effects of n-3 and n-6 fatty acids. Prog. Lipid Res. 2008, 47:147-155.
143. Schroer R.J., Phelan M.C., Michaelis R.C., Crawford E.C., Skinner S.A., Cuccaro M., Simensen R.J., Bishop J., Skinner C., Fender D., Stevenson R.E. Autism and maternally derived aberrations of chromosome 15q. Am. J. Med. Genet. 1998, 76:327-336.
144. Schwartz R.D., Yu X. Inhibition of GABA-gated chloride channel function by arachidonic-acid. Brain Res. 1992, 585:405-410.
145. Serhan C.N., Yacoubian S., Yang R. Anti-inflammatory and proresolving lipid mediators. Annu. Rev. Pathol. Mech. Dis. 2008, 3:279-312.
146. Simopoulos A.P. New products from the agri-food industry: the return of n-3 fatty acids into the food supply. Lipids 1999, 34:S297-S301.
147. Simopoulos A.P. Omega-3 fatty acids in inflammation and autoimmune diseases. J. Am. Coll. Nutr. 2002, 21:495-505.
148. Simopoulos A.P. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed. Pharmacother. 2006, 60:502-507.
149. Simopoulos A.P. Evolutionary aspects of diet: the omega-6/omega-3 ratio and the brain. Mol. Neurobiol. 2011, 44:203-215.
150. Sinn N., Bryan J., Wilson C. Cognitive effects of polyunsaturated fatty acids in children with attention deficit hyperactivity disorder symptoms: a randomised controlled trial. Prostaglandins Leukot. Essent. Fatty Acids 2008, 78:311-326.
151. Sliwinski S., Croonenberghs J., Christophe A., Deboutte D., Maes M. Polyunsaturated fatty acids: do they have a role in the pathophysiology of autism?. Neuro Endocrinol. Lett. 2006, 27:465-471.
152. Takeuchi T., Iwanaga M., Harada E. Possible regulatory mechanism of DHA-induced anti-stress reaction in rats. Brain Res. 2003, 964:136-143.
153. Tian C., Fan C., Liu X., Xu F., Qi K. Brain histological changes in young mice submitted to diets with different ratios of n-6/n-3 polyunsaturated fatty acids during maternal pregnancy and lactation. Clin. Nutr. 2011, 30:659-667.
154. Umezawa M., Ohta A., Tojo H., Yagi H., Hosokawa M., Takeda T. Dietary alpha-linolenate linoleate balance influences learning and memory in the Senescence-Accelerated Mouse (Sam). Brain Res. 1995, 669:225-233.
155. van de Rest O., van Hooijdonk L.W., Doets E., Schiepers O.J., Eilander A., de Groot L.C. B vitamins and n-3 fatty acids for brain development and function: review of human studies. Ann. Nutr. Metab. 2012, 60:272-292.
156. Vancassel S., Durand G., Barthelemy C., Lejeune B., Martineau J., Guilloteau D., Andres C., Chalon S. Plasma fatty acid levels in autistic children. Prostaglandins Leukot. Essent. Fatty Acids 2001, 65:1-7.
157. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 2005, 57:67-81.
158. Vinot N., Jouin M., Lhomme-Duchadeuil A., Guesnet P., Alessandri J.M., Aujard F., Pifferi F. Omega-3 fatty acids from fish oil lower anxiety, improve cognitive functions and reduce spontaneous locomotor activity in a non-human primate. PLoS ONE 2011, 6:e20491.
159. Volk H.E., Hertz-Picciotto I., Delwiche L., Lurmann F., McConnell R. Residential proximity to freeways and autism in the CHARGE study. Environ. Health Perspect. 2011, 119:873-877.
160. Wainwright P.E. Do essential fatty-acids play a role in brain and behavioral-development. Neurosci. Biobehav. Rev. 1992, 16:193-205.
161. Wainwright P.E. Dietary essential fatty acids and brain function: a developmental perspective on mechanisms. Proc. Nutr. Soc. 2002, 61:61-69.
162. Wallis J.G., Watts J.L., Browse J. Polyunsaturated fatty acid synthesis: what will they think of next?. Trends Biochem. Sci. 2002, 27:467-473.
163. Weintraub K. Autism counts. Nature 2011, 479:22-24.
164. Whelan J. (n-6) and (n-3) polyunsaturated fatty acids and the aging brain: food for thought. J. Nutr. 2008, 138:2521-2522.
165. Wing L., Potter D. The epidemiology of autistic spectrum disorders: is the prevalence rising?. Ment. Retard. Dev. Disabil. Res. Rev. 2002, 8:151-161.
166. Won H., Mah W., Kim E. Autism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses. Front. Mol. Neurosci. 2013, 6:19.
167. Yeargin-Allsopp M., Rice C., Karapurkar T., Doernberg N., Boyle C., Murphy C. Prevalence of autism in a US metropolitan area. J. Am. Med. Assoc. 2003, 289:49-55.
168. Yehuda S., Rabinovitz S., Mostofsky D.I. Essential fatty acids are mediators of brain biochemistry and cognitive functions. J. Neurosci. Res. 1999, 56:565-570.
169. Yehuda S., Rabinovitz S., Mostofsky D.I. PUFA: mediators for the nervous, endocrine, and immune systems. Fatty Acids: Physiological and Behavioral Functions 2001, 403-420. Humana Press Inc., Totowa, NJ. D.I. Mostofsky, S. Yehuda, N. Salem (Eds.).
170. Yehuda S., Rabinovitz S., Mostofsky D.I. Essential fatty acids and stress. Nutrients, Stress, and Medical Disorders 2005, 99-110. Humana Press, Totowa, NJ. S. Yehuda, D.I. Mostofsky (Eds.).
171. Yehuda S., Rabinovitz S., Mostofsky D.I. Essential fatty acids and the brain: from infancy to aging. Neurobiol. Aging 2005, 26(Suppl. 1):98-102.
172. Yoo H.J., Cho I.H., Park M., Cho E., Cho S.C., Kim B.N., Kim J.W., Kim S.A. Association between PTGS2 polymorphism and autism spectrum disorders in Korean trios. Neurosci. Res. 2008, 62:66-69.
173. Yui K., Koshiba M., Nakamura S., Kobayashi Y. Effects of large doses of arachidonic acid added to docosahexaenoic acid on social impairment in individuals with autism spectrum disorders: a double-blind, placebo-controlled, randomized trial. J. Clin. Psychopharmacol. 2012, 32:200-206.
174. Zimmer L., Delion-Vancassel S., Durand G., Guilloteau D., Bodard S., Besnard J.C., Chalon S. Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids. J. Lipid Res. 2000, 41:32-40.